Localized Renal Cell Carcinoma
Advertisement
Investigators used multivariable analysis and Kaplan-Meier analysis to compare partial nephrectomy with radical nephrectomy.
Drs. Woldu and Pierorazio presented on disparities in RCC care and outcomes as well as appropriate AS in small renal masses.
Surgery for locally advanced RCC may be safe for patients after neoadjuvant durvalumab with or without tremelimumab.
Researchers evaluated biomarkers to determine their prognostic potential for determining treatment modality for ccRCC.
Patients with early-onset RCC underwent genetic testing more often than those with bilateral RCC.
A Danish study suggests that diabetes has a significant impact on OS in patients with RCC who undergo nephrectomy.
A Merit Award-winning abstract offered insight into differences in RCC susceptibility and implications for genetic screening.
The anti-PD-1 therapy met the trial’s key secondary endpoint of OS for patients with RCC following nephrectomy.
Certain risk factors can result in pathological upstaging in patients treated with nephrectomy for nonmetastatic RCC.
New data compares renal function outcomes of SABR in patients with solitary versus bilateral kidneys.
Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation.
Hans Hammers, MD, PhD – Driving Immunotherapy Combinations Into the Modern Age of Kidney Cancer Care
Dr. Hammers discusses the kidney clinical trials he has led and shares his perspectives on novel IO and targeted therapies.
The da Vinci Single Port platform allows robot-assisted surgical procedures with the same precision as multiport techniques.
While nephrectomy is a common treatment for kidney cancer, it can result in loss of kidney function or kidney failure.
The EVEREST trial analyzed the effectiveness of everolimus in patients with RCC who have undergone full surgical resection.
Dr. Calais describes a novel radiotracer and explains how the recent data on this radiotracer further support its use.
Several experts discuss the evolution of nephrectomy, how it is used today, which patients are best suited for it, and more.
To identify positive surgical margins, researchers used DESI-MSI to to distinguish normal tissue from RCC tissue samples.
Tumor grade, sarcomatoid features may influence outcomes with adjuvant nivo/ipi in patients with RCC after nephrectomy.
Partial nephrectomy has been gaining traction as an effective treatment for RCC due to its safety and efficacy.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.